Oral Drug Delivery Resources

  1. Contract Design And Development Vs. In-House: How To Find The Best Fit 3/21/2024

    Explore the rationale behind opting for a contract development organization (CDO) to fulfill organizational requirements and underscore vital considerations for evaluating CDOs to ensure alignment with your project objectives.

  2. Integrating Early-Phase Clinical Supply Manufacturing & Distribution 5/10/2022

    A tablet formulation was a solution when developing a new class of anti-infective medicine, allowing the integration of formulation development, clinical trial material (CTM) manufacturing, and supply and distribution to patients.

  3. Age-Appropriate Pediatric Formulation Development 1/27/2022

    There is a significant variability in the pharmacokinetics of the same drug and dosage form between pediatric and adult populations, and the factors impacting drug bioavailability are different in children.

  4. Managing Poor Solubility With Cutting-Edge Formulation Approaches 8/24/2022

    An increasing number of poorly soluble APIs are the cornerstone of cutting-edge therapies, necessitating equally complex formulation technologies to maintain or improve solubility and, ultimately, bioavailability.

  5. Zydis® Orally Disintegrating Tablet (ODT) Vs. Standard Tablets (ST) 7/28/2023

    Review how Zydis ODT compares against standard oral tablets, how the same molecule can produce a different outcome when utilizing Zydis ODT, and findings from over 20 published studies.

  6. PBPK Modeling For Optimized Controlled Release Formulation Development 8/24/2023

    Examine the benefits of controlled release, the application of PBPK modeling in controlled release formulation development, and how modified release products can be developed to deliver optimal patient outcomes.

  7. Making A Case For A Fixed Dose Combination Drug Strategy

    As patient-centricity spurs innovation in drug delivery systems, examine the potential of FDCs to provide convenient dosing and how increased patient compliance is alleviating the cost of health care.

  8. Streamline Early-Stage Development To Reach The Clinic Faster 7/17/2023

    Early-stage development is an iterative process, continuously generating new data and insights to optimize the product based on emerging knowledge.

  9. Strategies For Successful Manufacturing Of Highly Potent Oral Solids 3/10/2025

    In this discussion, industry experts explore some of the key challenges in HPAPI drug product manufacturing and highlight essential factors sponsors should consider when evaluating a CDMO partner.

  10. Development Of Next Gen Sustained Release Solutions For Pain Management 2/22/2023

    A TheraPEA™ polymer based injectable formulation designed to deliver the same dose of Triamcinolone Acetonide (TAA) as in Zilretta® has shown promising results in a series of pre-clinical studies.